Go to main content
Estonia

Product Details

Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) for improving exercise capacity and alleviate disease symptoms in patients with New York Heart Association (NYHA) Functional Class III. 

Drug Facts

Active ingredient

Treprostinil sodium